Advanced BioMedical Technologies, Inc. (ABMT)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
May 16, 2025, 4:00 PM EDT
ABMT Cash Flow Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 2011 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '21 Jul 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 | Oct '18 Oct 31, 2018 | Oct '17 Oct 31, 2017 | Oct '16 Oct 31, 2016 | 2011 - 2015 |
| Net Income | -0.75 | -0.67 | -0.95 | -0.95 | -0.69 | -0.72 | Upgrade
|
| Depreciation & Amortization | 0.08 | 0.06 | 0.02 | 0.02 | 0.01 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.04 | - | Upgrade
|
| Stock-Based Compensation | 0.04 | 0.05 | 0.02 | 0.05 | - | 0.05 | Upgrade
|
| Other Operating Activities | -0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Change in Accounts Receivable | -0.01 | 0.02 | -0.02 | -0.02 | 0 | -0 | Upgrade
|
| Change in Inventory | -0.1 | -0.03 | -0.07 | - | - | 0 | Upgrade
|
| Change in Accounts Payable | 0.65 | 1.19 | 0.24 | 0.05 | 0.06 | 0.25 | Upgrade
|
| Change in Other Net Operating Assets | 0.11 | 0.01 | 0 | - | - | - | Upgrade
|
| Operating Cash Flow | 0.01 | 0.65 | -0.74 | -0.83 | -0.56 | -0.37 | Upgrade
|
| Capital Expenditures | -0.05 | -0.03 | -0.02 | -0.06 | -0 | -0 | Upgrade
|
| Other Investing Activities | - | - | - | - | 0 | - | Upgrade
|
| Investing Cash Flow | -0.05 | -0.03 | -0.02 | -0.06 | 0 | -0 | Upgrade
|
| Short-Term Debt Issued | - | 0.07 | 0.76 | 0.93 | 0.61 | 0.39 | Upgrade
|
| Total Debt Issued | 0.51 | 0.07 | 0.76 | 0.93 | 0.61 | 0.39 | Upgrade
|
| Short-Term Debt Repaid | - | -0.45 | - | -0.03 | -0.05 | -0.05 | Upgrade
|
| Long-Term Debt Repaid | - | -0.04 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -0.48 | -0.49 | - | -0.03 | -0.05 | -0.05 | Upgrade
|
| Net Debt Issued (Repaid) | 0.02 | -0.42 | 0.76 | 0.9 | 0.56 | 0.34 | Upgrade
|
| Other Financing Activities | -0 | -0 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 0.02 | -0.43 | 0.76 | 0.9 | 0.56 | 0.34 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | 0.01 | -0 | -0 | 0 | -0 | Upgrade
|
| Net Cash Flow | -0.01 | 0.2 | -0 | -0 | 0 | -0.03 | Upgrade
|
| Free Cash Flow | -0.04 | 0.62 | -0.76 | -0.9 | -0.56 | -0.37 | Upgrade
|
| Free Cash Flow Margin | -39.45% | 498.40% | -6529.08% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Cash Interest Paid | - | 0 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | 0.43 | 0.88 | -0.41 | -0.61 | -0.37 | -0.2 | Upgrade
|
| Unlevered Free Cash Flow | 0.62 | 1.08 | -0.2 | -0.42 | -0.21 | -0.04 | Upgrade
|
| Change in Net Working Capital | -0.82 | -1.28 | -0.16 | 0.03 | -0.03 | -0.16 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.